Electrocore Inc is a medical technology company focused on developing non-invasive neuromodulation therapies to treat various conditions, particularly those related to the central nervous system. The company specializes in innovative solutions that utilize electrical stimulation to modulate nerve activity, aiming to address ailments such as migraines, cluster headaches, and other chronic pain conditions. By leveraging its proprietary technology, Electrocore seeks to provide patients with alternative treatment options that can enhance their quality of life while minimizing reliance on traditional pharmaceuticals. The company's commitment to research and development underscores its goal of advancing neuromodulation as a viable therapeutic approach in the healthcare landscape. Read More
electroCore (ECOR) Q2 2025 earnings show revenue beat at $7.38M (+20% YoY) but EPS missed at -$0.35, sparking a 20% stock drop. Growth continues, but profitability concerns persist.
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.
LONDON, UNITED KINGDOM / ACCESSWIRE / September 4, 2024 / Ecora Resources PLC (LSE/TSX:ECOR) announces half year results for the six months ended 30 June 2024 which are available on both the Group's website at www.ecora-resources.com and on SEDAR at www.sedar.com.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
RALEIGH, NC / ACCESSWIRE / September 25, 2023 / iAccess Alpha's Top 10 Best Ideas from the buyside virtual conference is taking place September 26th & 27th, 2023.
